New England ATTC at Brown University

The New England Addiction Technology Transfer Center is part of a national network consisting of 10 regional centers, 4 national focus areas and a coordinating office that provide services to all US states and territories. As a multidisciplinary resource for professionals in the substance use disorders treatment and recovery support services field, the ATTC Network serves to:

  • Raise awareness of evidence-based and promising treatment and recovery practices,
  • Build skills to prepare the workforce to deliver state-of-the-art addiction treatment and recovery services, and
  • Change practice by incorporating these new skills into everyday use for the purpose of improving addiction treatment and recovery outcomes.


News and Events:

Webinette Series

AAP Fetal Alcohol Spectrum Disorders Webinar Series
We are pleased to share the following information on three AAP webinars that will take place in January and February as part of our CDC FASD Practice and Implementation Centers (PICs) and National Partners efforts…..
The American Academy of Pediatrics (AAP) is offering a series of three 30-minute educational webinars focused on enhancing the education of pediatric primary care clinicians regarding fetal alcohol spectrum disorders (FASDs). The educational webinars will feature clinical practices including identification, diagnosis and care planning for children with FASDs. The webinars are open to all clinical personnel, with practicing primary care clinicians strongly encouraged to attend.
Faculty: Carol Weitzman, MD, FAAP
Wednesday, January 18 at 4 pm ET | 3 pm CT | 2 pm MT | 1 pm PT
About the Webinar
This webinar will focus on defining the terms used to describe the conditions that fall under the umbrella of fetal alcohol spectrum disorders (FASDs), describing the signs that may indicate prenatal alcohol exposure and a possible condition along the continuum of FASDs. Participants will be oriented to the diagnostic assessment including the areas of the brain affected by prenatal alcohol exposure, approaches to delivering the diagnosis, and indications for referral. Faculty will reinforce the benefits of a diagnosis and demonstrate how to address issues around stigma in both assessing for prenatal alcohol exposure and delivering a FASDs diagnosis.
Learning Objectives
At the end of this webinar, participants will be able to:
1.      Define FASD and its component conditions and explain its relevance to pediatric practice.
2.      Describe the neurobehavioral and physical characteristics of FASDs.
3.      Explain diagnostic criteria and the diagnostic process.
Register here for this webinar!
Faculty: Douglas Waite, MD, FAAP
Wednesday, January 25, 2017 at 4 pm ET | 3 pm CT | 2 pm MT | 1 pm PT
About the Webinar
This webinar will focus on the factors in a patient’s medical history and clinical presentation that may indicate the presence of Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure (ND-PAE). Participants will learn about the three domains in which children with this disorder struggle with behavior and developmental tasks. The definition of ND-PAE from the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and related issues regarding more than minimal exposure to alcohol will be shared. The ways that ND-PAE may present in clinic through the developmental stages and strategies for managing care will be covered.
Learning Objectives
At the end of this webinar, participants will be able to:
1.      Identify the signs and symptoms that may indicate the presence of Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure (ND-PAE). ND-PAE is one of the Fetal Alcohol Spectrum Disorders.
2.      Discuss the diagnostic criteria for ND-PAE, including relevant testing.
3.      Describe management strategies for ND-PAE.
Register here for this webinar!
Faculty: Yasmin Senturias, MD, FAAP
Wednesday, February 1, 2017 at 4 pm ET | 3 pm CT | 2 pm MT | 1 pm PT
About the Webinar
This webinar will aim to provide primary care clinicians with the tools they need to treat children with FASDs across the lifespan. The session will focus on identifying and managing neurobehavioral and medical concerns at different developmental stages. Participants will learn about medical, therapeutic, and pharmaceutical considerations. Faculty will present evidence-based interventions that are applicable to community-based primary care pediatricians. Specifically, approaches to building parent knowledge and working with the school system on individualized education programs (IEPs) and 504 Plans will be discussed. Support services and resources for providers, families, and teachers/schools will also be covered.
Learning Objectives
At the end of this webinar, participants will be able to:
1.      Describe developmental and functional concerns for individuals with FASDs and management strategies across the life span.
2.      Explain various treatment approaches, including evidence-based approaches specific to FASDs
3.      Explain support services and resources for families, providers, and schools.
4.      Discuss issues related to children with FASD and the criminal justice system.
Register here for this webinar!
For questions regarding the webinar, please contact Josh Benke at, or Nkem Chineme



            A national campaign to address the substance use treatment needs of adolescents.

Join us for the fourth webinar in the quarterly series on new approaches in evidence-based prevention and substance use disorder treatment for youth:


Substance Use Disorder &
The Adolescent Brain


The National Institute on Drug Abuse (NIDA) is the lead federal agency supporting scientific research on substance use disorders (SUDs). As part of their mission, NIDA is responsible for providing information on both the short and long term consequences of SUDs on the brains, bodies and lives of adolescents. NIDA’s comprehensive website provides a variety of tools (e.g., videos, infographics, blogs, publications) that address adolescent substance use and are available at no cost.

This webinar will focus on the adolescent brain, provide information on those adolescents who are at increased risk for drug use, and present the major impact of home, family and peers. In addition, the presenter will address the increased potency of THC/marijuana and its potential long-term impact on this population.


Glen R. Hanson, DDS, PhD is the Associate Dean for the School of Dentistry at the University of Utah and the Director of the Utah Addiction Center, University of Utah. Previously, Dr. Hanson served as the Acting Director of the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) and as the Director of NIDA's Division of Neurobiology and Behavioral Research. Dr. Hanson is recognized as one of the world's leading experts on the neurobiology of psycho-stimulants including methamphetamine and ecstasy (MDMA).

Date:  Tuesday, January 17, 2017

Time: 1:00pm - 2:00pm Eastern (12pm Central / 11am Mountain /10am Pacific)



Announcing a New Product:



Substance Use, HIV, and Women: What Clinicians Need to Know

The purpose of this introductory training is to provide HIV clinicians (including, but not limited to physicians, dentists, nurses, and other allied medical staff, therapists and social workers, and counselors, specialists, and case managers) with a detailed overview of substance abuse and HIV among women. The curriculum reviews important epidemiological data focused on substance use trends in women and HIV prevalence; reviews standardized screening and assessment techniques to support the move to improve treatment effectiveness; and concludes with evidence-based and promising clinical strategies. The introductory training includes a 112-slide PowerPoint presentation, Trainer Guide, and a companion 2-page fact sheet. The duration of the training is approximately 90-120 minutes, depending on whether the trainer chooses to present all of the slides, or a selection of slides.


What Does the Training Package Contain?

·    Training Slides (PPT)

·    Trainer Guide (PDF)

·    2-page Fact Sheet (PDF)

To view and download the training package, please visit:


Past Events:


ATTC Center of Excellence on Behavioral Health for Pregnant and Postpartum Women and Their Families (ATTC CoE-PPW)

The ATTC Center of Excellence on Behavioral Health for Pregnant and Postpartum Women and Their Families (ATTC CoE-PPW) was established to develop a family- centered treatment national curricula, web-based toolkit, and provides support for national training efforts through the ATTC Network. Click HERE for more information.

Webinette Series

November 8, 2016

Presenter Name: Hanh Dao, MSW

Title: Developing a Collaborative Approach to Address the Opioid Epidemic

Brief Overview: The rate of opioid misuse and dependence is escalating in many communities. The systems working with affected families are struggling to develop a comprehensive approach. These systems often have varying perspectives on the primary client and thus on the intended outcome. The systems operate under a considerable range of policies, approaches, practice and access to resources. These differences across, and sometimes, within systems affect service coordination and can create further challenges for families. The challenges are often magnified in situations involving pregnant women and their infants. Join this webinette to learn of tools and resources available from the newly published document, A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders: Practice and Policy Considerations for Child Welfare, Collaborating Medical, and Service Providers.